Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Adicet Bio Inc

ACET
Current price
2.19 USD +0.03 USD (+1.39%)
Last closed 2.2 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 177 452 640 USD
Yield for 12 month -64.33 %
1Y
3Y
5Y
10Y
15Y
ACET
21.11.2021 - 28.11.2021

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. The company is also developing ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma for treating other CD70+ solid tumor and hematological malignancies indications. The company was founded in 2014 and is based in Boston, Massachusetts. Address: 131 Dartmouth Street, Boston, MA, United States, 02116

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+24 990 000 USD

Current Quarter

Last Quarter

Current Year

-6 098 000 USD

Last Year

+19 981 000 USD

Current Quarter

-1 689 000 USD

Last Quarter

-2 348 000 USD

Key Figures ACET

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -126 478 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -30.8 %
PEG Ratio 0.82
Return On Equity TTM -61.69 %
Wall Street Target Price 9 USD
Revenue TTM
Book Value 3.93 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 24 990 000 USD
Earnings Share -3.31 USD
Diluted Eps TTM -3.31 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ACET

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ACET

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:7
Payout Ratio
Last Split Date 16.09.2020
Dividend Date 16.09.2020

Stock Valuation ACET

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.1386
Price Sales TTM 9.7185
Enterprise Value EBITDA -0.2832
Price Book MRQ 1.0428

Financials ACET

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ACET

For 52 weeks

1.1 USD 7.5 USD
50 Day MA 2.49 USD
Shares Short Prior Month 5 812 895
200 Day MA 2.06 USD
Short Ratio 5.24
Shares Short 7 687 094
Short Percent 10.84 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

414.58 USD Microsoft Corporation +0.12 (+0.03%)
Detailed analytics

ETF funds


M

MDAXEX

208.70 CHF iShares MDAX UCITS ETF (DE) -11.84 (-4.92%)
Detailed analytics

Metals


Gold

2169.94 USD Gold -5.94 (-0.27%)
Detailed analytics